Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438627
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-24
Brief Title:
Efficacy and Safety of TPCApatinibCamrelizumab vs GP Camrelizumab for High-Risk Nasopharyngeal Carcinoma A Phase 3 Trial
Sponsor:
XIANG YANQUN
Organization:
Sun Yat-sen University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Nasopharyngeal Carcinoma |
Keywords: